Nitric oxide-compromised hypertension: Facts and enigmas

Physiological Research

Volumn 49, Issue 1, 2000, Pages 27-35

  Gerova M ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Hypertension; Hypothalamus; L NAME acute administration; L NAME chronic administration; NO level in vivo; Polyamines

Indexed keywords

ACETYLCHOLINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; ORNITHINE DECARBOXYLASE; POLYAMINE;

ANIMAL MODEL; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOG; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMORAL ARTERY; FEMORAL VEIN; HEART HYPERTROPHY; HYPERTENSION; HYPOTHALAMUS; NONHUMAN; RAT; SHORT SURVEY; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; DOGS; ENZYME INHIBITORS; HYPERTENSION; HYPOTHALAMUS, POSTERIOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS;

EID: 0033964055     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (47)

1. ADDICKS K, BLOCH W, FEELISCH M: Nitric oxide modulates sympathetic neurotransmission at the prejunctional level. Microscopy Res Tech 29: 161-168, 1994.
2. ARNAL JF, EL AMRANI AI, CHATELLIER G, MÉNARD J, MICHEL JB: Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 22: 380-387, 1993.
3. BABÁL P, PECHÁŇOVÁ O, BERNÁTOVÁ I, ŠTVRTINA S: Chronic inhibition of NO synthesis produces myocardial fibrosis and arterial media hyperplasia. Histol Histopathol 12: 623-629, 1997.
4. BANTING JD, THOMPSON KE, FRIBERG P, ADAMS MA: Blunted cardiovascular growth induction during prolonged nitric oxide synthase blockade. Hypertension 30: 416-421, 1997.
5. BARTOLOME J, HUGUENARD J, SLOTKIN TA: Role of ornithine decarboxylase in cardiac growth and hypertrophy. Science 210: 793-794, 1980.
6. BAYLIS C, MITRUKA B, DENG A: Chronic blockade of nitric oxide synthases in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90: 278-281, 1992.
7. BERNHARDT J, TSCHUDI MR, DOHI Y, GUT I, URWYLER B, BÜHLER FR, LÜSCHER TF: Release of nitric oxide from human vascular smooth muscle cells. Biochem Biophys Res Commun 180: 907-912, 1991.
8. BOULANGER CM, HEYMES CH, BENESSIANO J, GESKE RS, LÉVY BI, VANHOUTTE PM: Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res 83: 1271-1278, 1998.
9. DELACRETAZ E, HAYOZ D, OSTERHELD MC, GENTON CY, BRUNNER HR, WEBER B: Long-term nitric oxide synthase inhibition and distensibility of carotid artery in infant rats. Hypertension 23: 967-970, 1994.
10. DUN NJ, DUN SL, WU SY, FÖRSTERMANN U: Nitric oxide synthase immunoreactivity in rat superior cervical ganglia and adrenal glands. Neurosci Lett 158: 51-54, 1993.
11. EGBERONGBE YI, GENTLEMAN SM, FALKAI P, BOGERTS B, POLAK JM, ROBERTS GW: The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 59: 561-578, 1994.
12. FOLKOW B: Physiological aspects of primary hypertension. Physiol Rev 62: 347-504, 1982.
13. FURCHGOTT RF, ZAWADZKI JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
14. GEROVÁ M: NO compromised hypertension: facts and enigmas. Physiol Res 48: 30P, 1999.
15. GEROVÁ M, MAŠÁNOVÁ C, PAVLÁSEK J: Inhibition of NO synthase in the posterior hypothalamus increases blood pressure in the rat. Physiol Res 44: 131-134, 1995.
16. GEROVÁ M, MESAROŠ Š, KITTOVÁ M, HATRIK Š, KRISTEK F, MALINSKI T: Nitric oxide in the periendothelial area of femoral vein of the dog assessed in vivo by a porphyrinic sensor. Physiol Res 45: 285-289, 1996a.
17. GEROVÁ M, PECHÁŇOVÁ O, STOEV V, KITTOVÁ M, BERNÁTOVÁ I, BARTA E: Early changes in protein synthesis in epicardial coronary artery of pressure-overloaded heart. Am J Physiol 270: H685-H691, 1996b.
18. GEROVÁ M, HARTMANNOVÁ B, DOLEŽEL S, JEŽEK L: Long-term inhibition of NO synthase induces cardiac hypertrophy with a decrease in adrenergic innervation. Physiol Res 45: 339-344, 1996c.
19. GEROVÁ M, MESAROŠ Š, KRISTEK F, KITTOVÁ M, MALINSKI T: NO concentration in the periendothelial area of the femoral artery of the dog measured in vivo. Physiol Res 47: 169-175, 1998a.
20. GEROVÁ M, PECHÁŇOVÁ O, BERNÁTOVÁ I, KITTOVÁ M, JURÁNI M: Early changes of protein synthesis in myocardium and coronary arteries induced by NO synthase inhibition. Physiol Res 47: 405-412, 1998b.
21. HOLÉCYOVÁ A, TÖRÖK J, BERNÁTOVÁ I, PECHÁŇOVÁ O: Restriction of nitric oxide rather than elevated blood pressure is responsible for alterations of vascular responses in nitric oxide-deficient hypertension. Physiol Res 45: 317-321, 1996.
22. KELLY RA, BALLIGAND JL, SMITH TW: Nitric oxide and cardiac function. Circ Res 79: 363-380, 1996.
23. KELM M, PREIK-STEINHOFF H, PREIK M, STRAUER BE: Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway. Cardiovasc Res 41: 765-772, 1999.
24. KLIMASCHEWSKI L, KUMMER W, MAYER B, COURAUD JY, PREISSLER U, PHILIPPIN B, HEYM C: Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart. Circ Res 71: 1533-1537, 1992.
25. KONE BC, BAYLIS C: Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 272: F561-F578, 1997.
26. KRISTEK F, GEROVÁ M: Long-term NO synthase inhibition affects heart weight and geometry of coronary and carotid arteries. Physiol Res 45: 361-367, 1996.
27. KRISTEK F, GEROVÁ M, DEVÁT L, VARGA I: Remodeling of septal branch of coronary artery and carotid artery in L-NAME treated rats. Physiol Res 45: 329-333, 1996
28. 1-receptor antagonists do not prevent the appearance of endothelium-dependent relaxation to acetylcholine in rat pulmonary artery. Physiol Res 45: 245-350, 1996.
29. LI JS, SCHIFFRIN EL: Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase. Am J Hypertens 1: 996-1004, 1994.
30. LIU Y, TSUCHIHASHI T, KAGIYAMA S, MATSUMURA K, ABE I, FUJISHIMA M: Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats. J Hypertens 16: 1165-1173, 1998.
31. MALINSKI T, TAHA Z: Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 358: 676-678, 1992.
32. MATSUSHITA S, SOGANI RK, RABEN MS: Ornithine decarboxylase in cardiac hypertrophy in the rat. Circ Res 31: 699-709, 1972.
33. PALMER RMJ, FERRIGE AG, MONCADA S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
34. PALMER RMJ, ASHTON DS, MONCADA S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988.
35. PAXINOS G, WATSON C (eds): The Rat Brain. Academic Press, London, 1982.
36. PECHÁŇOVÁ O, BERNÁTOVÁ I, PELOUCH V, BABÁL P: L-NAME induced protein remodeling and fibrosis in the rat heart. Physiol Res 48: 353-362, 1999.
37. PEUNOVA N, ENIKOLOPOV G: Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 375: 68-73, 1995.
38. REES DD, PALMER RMJ, SCHULZ R, HODSON HF, MONCADA S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746-752, 1990.
39. RIBEIRO MO, ANTUNES E, DE NUCCI G, LOVISOLO SM, ZATZ R: Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 20: 298-303, 1992.
40. RODRIGO J, SPRINGALL DR, UTTENTHAL O, BENTURA ML, ABADIA-MOLINA F, RIVEROS-MORENO V, MARTINEZ-MURILLO R, POLAK JM, MONCADA S: Localization of nitric oxide synthase in the adult rat brain. Phil Trans R Soc Lond B 345: 175-221, 1994.
41. SANDER M, HANSEN PG, VICTOR RG: Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide. Hypertension 26: 691-695, 1995.
42. SCROGIN KE, HATTON DC, CHI Y, LUFT FC: Chronic nitric oxide inhibition with L-NAME: effects on autonomie control of the cardiovascular system. Am J Physiol 274: R367-R374, 1998.
43. SHAPOVAL LN, SAGACH VF, POBEGAILO LS: Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett 132: 47-50, 1991.
44. SLÁDEK T, GEROVÁ M, ZNOJIL V, DEVÁT L: Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase. Physiol Res 45: 335-338, 1996.
45. TODA N, OKAMURA T: Regulation by nitroxidergic nerve of arterial tone. News Physiol Sci 7: 148-152, 1992.
46. URSELL PC, MAYES M: Anatomic distribution of nitric oxide synthase in the heart. Int J Cardiol 50: 217-223, 1995.
47. ZANZINGER J, CZACHURSKI J, SELLER H: Nitric oxide in the ventrolateral medulla regulates sympathetic responses to systemic hypoxia in pigs. Am J Physiol 275: R33-R39, 1998.